Healthcare Regulatory Affairs Outsourcing Market
Market Insights on Healthcare Regulatory Affairs Outsourcing covering sales outlook, demand forecast & up-to-date key trends
Healthcare Regulatory Affairs Outsourcing Market by Services (Regulatory Writing and Publishing, Regulatory Submission, Clinical Trial Applications, Regulatory Consulting, Legal Representation) End User and Region for 2022 - 2028
Healthcare Regulatory Affairs Outsourcing Market Snapshot
[140 Pages Report] The global Healthcare Regulatory Affairs Outsourcing Market is slated to total US$ 1.76 Bn in 2022, as per a recent market study by Future Market Insights (FMI). Rising cases of various chronic ailments along with high costs associated with research and development activities will remain chief drivers of the market.
Approval time of drugs and other medical equipment is a costly, time-consuming, and documentation-centric procedure. With increasing focus on novel drug development in the healthcare sector, various firms are partnering with outsourcing companies for faster documentation and approvals.
Against this backdrop, sales are projected to increase at a stupendous 13.5% CAGR, pushing the healthcare regulatory affairs outsourcing market size to US$ 2.54 Bn in 2028.
|
Attribute |
Details |
|
Estimated Healthcare Regulatory Affairs Outsourcing Market Size 2022 |
US$ 1.76 Bn |
|
Healthcare Regulatory Affairs Outsourcing Market Value-based CAGR (2022-2028) |
~13.5% |
|
Projected Healthcare Regulatory Affairs Outsourcing Market Size in 2028 |
US$ 2.54 Bn |
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
12.20% |
|
H1, 2022 Projected |
13.46% |
|
H1, 2022 Outlook |
11.86% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 160 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 34 ↓ |
The comparative analysis and market growth rate of global healthcare regulatory affairs outsourcing market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 160 BPS, and, a dip in BPS value is expected in H1-2022 over H1- 2021 duration with 34 Basis Point Share (BPS).
The outsourcing cost of regulatory affairs is quite high, and the companies or organizations which opt to outsource regulatory affairs may not be in a state to conduct an in-house evaluation. Furthermore, during outsourcing, there is initiated, a necessity that there must be risk management plan of outsourcing, which include considerations of cost if the outsourcing of regulatory affairs is discontinued.
On the other hand, switching to CROs costs money for the organisations. The corporation may decide to adjust its outsourcing policy such that it internally sources regulatory affairs work instead, which would result in higher operational costs. The BPS value has decreased as a result of this factor.
Additionally, organisations fear that outsourcing regulatory affairs work to CROs may result in the loss of important internal capabilities. Given that when outsourced regulatory knowledge is needed, the situation in a firm may be urgent, it is crucial that CROs have enough resources to acquire flexibility. These factors cumulatively induce a decline in the BPS value, as observed.
Rising cases of various chronic ailments along with high costs associated with research and development activities will remain chief drivers of the market.
Approval time of drugs and other medical equipment is a costly, time-consuming, and documentation-centric procedure. With increasing focus on novel drug development in the healthcare sector, various firms are partnering with outsourcing companies for faster documentation and approvals.
2012-2021 Healthcare Regulatory Affairs Outsourcing Market in Comparison to 2022-2028 Demand Outlook
Demand for healthcare regulatory affairs outsourcing is projected to increase at an impressive 13.5% CAGR, in comparison with the 10.8% CAGR registered between 2012 and 2021.
The expansion of the healthcare sector worldwide is compelling biotechnology and pharmaceutical companies to outsource regulatory affairs to save costs and leverage the expertise available with contract research organizations (CROs). This process allows companies to save time and improve their core competencies, which is a chief driver of the market.
Regulatory support is available for most of the processes across clinical trials, such as manufacturing and controls (CMC), medial report writing, regulatory chemistry, data management, country regulatory affairs, regulatory strategy, and labeling & liaison.
Outsourcing these non-core activities to experts enables healthcare organizations to focus on their marketing and research and development activities. In the long run, companies can benefit from product approvals, optimized reimbursements, and increased productivity.
Owing to these factors, the market is anticipated to witness an upward trajectory in growth over the forecast period, opines FMI.
How Will Optimization of Vendor Networks Impact Market?
In the last few years, the optimization of vendor networks in large pharmaceutical companies has gained traction at a significant pace. To speed up the regulatory process, companies are trying to reduce the number of vendors to ensure a consistent and higher quality service.
This also enabled companies to apply a centralized approach, reduce resources required for vendor oversight, and achieve higher effectiveness and efficiency. In addition to this, outsourcing via third-party vendors is gaining traction, which again, leads to a significant reduction in costs.
Outsourcing vendor management offers process standardization and consistency, transparency, and effective governance. This trend is more prevalent in clinical operations, however, within the last few years it has become highly sought-after in regulatory affairs and pharmacovigilance.
Further, companies are investing in innovative outsourcing services providers to ensure high-quality delivery. Large pharmaceutical companies are trying to achieve higher quality standards than the minimum target set by regulatory bodies.
By choosing innovative vendors over generic ones, companies are paying more attention to management and governance, quality and compliance, regulatory intelligence process, team experience and engagement, and the vendor's internal structure and procedures. Through this, they are attempting to speed up the clinical trials and product approval process, which is expected to boost the market in the forthcoming years.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
Why is the U.S. Healthcare Regulatory Affairs Outsourcing Market Witnessing High Demand?
The U.S. is expected to emerge as a lucrative pocket owing to the presence of a robust healthcare sector and various small and large pharmaceutical and biotechnological companies. As per FMI, sales in the North America market are projected to command 30% of the total market share in 2022.
Stringent compliances issued by regulatory authorities are encouraging collaborations between drug developers and clinical research organizations (CROs) and contract manufacturing organizations. (CMOs) to mitigate potential risks and speed up the approval process.
In addition to this, various generic drugs are reaching their expiration dates, which is expected to boost sales in the market. Increasing research and development for novel drugs, vaccines, and medical equipment in the U.S. will continue augmenting the growth of the market in the forthcoming years.
How Will the U.K. Healthcare Regulatory Affairs Outsourcing Market Fare?
Demand in the Europe market is projected to account for 23% of the total market share in 2022, with the U.K. emerging as a lucrative pocket over the forecast period.
The license for marketing and authorization of new drugs in the U.K. is granted by regulatory authority, allowing the product to be sold by license holder in countries covered by the regulatory authority.
From January 2021, the Medicines and Healthcare Products Regulatory Agency (MHRA) carried out the licensing of new medicines in England, Scotland and Wales. In Northern Ireland, new medicines are being licensed by the European Commission, following the recommendations from the European Medicines Agency (MEA).
Further, the National Institute for Health and Care Excellence (NICE) for England and Wales and the Scottish Medicines Consortium (SMC) for Scotland appraise certain new medicines and investigate issues such as cost-effectiveness and efficacy in new treatments.
Due to the extensive approval process, demand for outsourcing services is on the rise. This trend is expected to continue over the forecast period, thereby fueling the growth of the market.
Why is the China Healthcare Regulatory Affairs Market Considered Attractive?
Favorable government investments and policies in the expansion of the healthcare sector in China are expected to place it as an attractive pocket in the Asia Pacific market. Demand in the Asia Pacific market is projected to hold 27.4% of the total market share in 2022.
Various pharmaceutical companies are aiming to expand their presence in China, which will require them to invest in outsourcing services for documentation, clinical trial applications, product registrations, and legal representation. This is expected to continue boosting sales in the market.
Besides this, regional pharmaceutical companies are focusing on generic domestic drug pricing and reimbursement reforms, such as a government-backed centralized drug procurement policy. This ensures lower bid contracts and guaranteed sales volume of drugs.
Lower costs are encouraging generic drug industry consolidation. However, companies are also focusing on global expansion, which in turn is spurring demand for outsourcing services for better compliance and faster drug approvals.
Category-wise Insights
Which is the Most Preferred Healthcare Regulatory Affairs Outsourcing Service?
Based on services, sales in the clinical trial application segment are projected to remain high over the forecast period. Growing emphasis on improving efficiency and reducing research and development costs is boosting sales in this segment.
Clinical trial outsourcing allows companies to leverage therapeutic areas and operational expertise, enabling them to expand the geographical reach and access well-established processes and tools while saving costs.
Besides this, ongoing development of specialized therapeutic drugs in areas such as oncology is expected to fuel sales in the forthcoming years. Outsourcing allows small and medium-size companies to conduct clinical trials in areas where the company itself may not have adequate expertise or resources to develop the product independently.
Why is Demand in Biotechnology Companies Rising?
In terms of end users, the biotechnology segment is expected to emerge as the most lucrative area of application in the market, with demand expected to grow at a considerable pace over the assessment period.
Increasing number of documentation during drug and medical device manufacturing is spurring demand for regulatory affairs outsourcing services. Small and medium-size biotechnology companies struggle with extensive documentation, which is compelling them to invest in outsourcing services.
In addition to this, due to strong regulations, demand for skilled professionals for handling registration, evaluation, and compliance of data is required. Owing to this factor, demand in the biotechnology segment is anticipated to gain momentum over the assessment period.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Competition Landscape
Leading players operating in the global healthcare regulatory affairs outsourcing market are investing in mergers, acquisitions, and collaborations to expand their global presence. Through this strategy, players are aiming at gaining a competitive edge. For instance:
- In October 2021, Paraxel and Kyoto University Hospital announced a strategic collaboration aimed at offering more opportunities for clinical research and productive ways of supporting clinical studies.
- In April 2021, IQVIA announced that it has acquired Quest Diagnostics’ minority stake in Q2 Solutions, a central laboratory services joint venture.
Scope of Report
|
Attribute |
Details |
|
Forecast Period |
2012-2021 |
|
Historical Data Available for |
2022-2028 |
|
Market Analysis |
Units for Volume and US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA |
|
Key Countries Covered |
United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others. |
|
Key Market Segments Covered |
Services, End User, and Region |
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Healthcare Regulatory Affairs Outsourcing Market by Category
Services:
- Regulatory Writing and Publishing
- Regulatory Submissions
- Clinical Trial Applications
- Product Registrations
- Regulatory Consulting and Legal Representation
End User:
- Mid-Size Pharmaceutical Companies
- Large Pharmaceutical Companies
- Biotechnology Companies
- Medical Devices Manufacturer
- Food & Beverage Companies
Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
Frequently Asked Questions
The global healthcare regulatory affairs outsourcing market is expected to reach a valuation of US$ 1763.1 Mn in 2022.
The global healthcare regulatory affairs outsourcing market grew at an impressive 10.8% CAGR between 2012 and 2021.
Ongoing development of novel therapeutic drugs, along with growing stringency in the regulatory framework are chief factors driving sales in the market.
PAREXEL International Corporation, Quintiles IMS Holdings Inc., Clinilabs, Inc., Accell Clinical Research, LLC., Freyr Solutions, The Weinberg Group Inc., Covance, Inc., (LabCorp), Pharmaceutical Product Development LLC, ICON plc and Sciformix Corporation are some of the leading players operating in the global healthcare regulatory affairs outsourcing market.
North America healthcare regulatory affairs outsourcing market is projected to account for 30% of the total market share during the forecast period.
The healthcare regulatory affairs outsourcing market in Europe is anticipated to account for 23% of the total market share over the assessment period.
Table of Content
1. Global Healthcare Regulatory Affairs Outsourcing Market - Executive Summary
2. Research Methodology
3. Assumptions and Acronyms Used
4. Global Healthcare Regulatory Affairs Outsourcing Market Overview
4.1. Introduction
4.1.1. Healthcare Regulatory Affairs Outsourcing Market Taxonomy
4.1.2. Healthcare Regulatory Affairs Outsourcing Market Definition
4.2. Global Healthcare Regulatory Affairs Outsourcing Market Size and Forecast
4.2.1. Global Healthcare Regulatory Affairs Outsourcing Market Y-o-Y Growth
4.2.2. Global Healthcare Regulatory Affairs Outsourcing Market Absolute $ Opportunity
4.3. Global Healthcare Regulatory Affairs Outsourcing Market Dynamics
4.3.1. Macro-economic Factors
4.3.2. Drivers
4.3.2.1. Supply Side
4.3.2.2. Demand Side
4.3.3. Restraints
4.3.4. Opportunities
4.3.5. Trends
4.3.6. Forecast Factors – Relevance and Impact
5. Global Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By Services
5.1. Introduction
5.1.1. Basis Point Share (BPS) Analysis By Services
5.1.2. Y-o-Y Growth Projections By Services
5.2. Market Size (US$ Mn) and Forecast By Services
5.2.1. Regulatory Writing and Publishing
5.2.2. Regulatory Submissions
5.2.3. Clinical Trial Applications and Product Registrations
5.2.4. Regulatory Consulting and Legal Representation
5.2.5. Other Regulatory Affairs
5.3. Market Attractiveness Analysis By Services
6. Global Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By End User
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis By End User
6.1.2. Y-o-Y Growth Projections By End User
6.2. Market Size (US$ Mn) and Forecast By End User
6.2.1. Mid-Size Pharmaceutical Companies
6.2.1. Large Pharmaceutical Companies
6.2.2. Biotechnology Companies
6.2.3. Medical Devices Companies
6.2.4. Food & Beverage Companies
7. Global Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast, By Region
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis By Region
7.1.2. Y-o-Y Growth Projections By Region
7.2. Market Size (US$ Mn) and Forecast By Region
7.2.1. North America
7.2.2. Latin America
7.2.3. Europe
7.2.4. Asia Pacific
7.2.5. Middle East & Africa
7.3. Market Attractiveness Analysis By Region
8. North America Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis By Country
8.1.2. Y-o-Y Growth Projections By Country
8.2. Market Size (US$ Mn) and Forecast By Country
8.2.1. U.S.
8.2.2. Canada
8.3. Market Size (US$ Mn) and Forecast By Services
8.3.1. Regulatory Writing and Publishing
8.3.2. Regulatory Submissions
8.3.3. Clinical Trial Applications and Product Registrations
8.3.4. Regulatory Consulting and Legal Representation
8.3.5. Other Regulatory Affairs
8.4. Market Size (US$ Mn) and Forecast By End user
8.4.1. Mid-Size Pharmaceutical Companies
8.4.2. Large Pharmaceutical Companies
8.4.3. Biotechnology Companies
8.4.4. Medical Devices Companies
8.4.5. Food & Beverage Companies
8.5. Market Attractiveness Analysis
8.5.1. By Country
8.5.2. By Services
8.5.3. By End user
9. Latin America Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.2. Market Size (US$ Mn) and Forecast By Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Market Size (US$ Mn) and Forecast By Services
9.3.1. Regulatory Writing and Publishing
9.3.2. Regulatory Submissions
9.3.3. Clinical Trial Applications and Product Registrations
9.3.4. Regulatory Consulting and Legal Representation
9.3.5. Other Regulatory Affairs
9.4. Market Size (US$ Mn) and Forecast By End user
9.4.1. Mid-Size Pharmaceutical Companies
9.4.2. Large Pharmaceutical Companies
9.4.3. Biotechnology Companies
9.4.4. Medical Devices Companies
9.4.5. Food & Beverage Companies
9.5. Market Attractiveness Analysis
9.5.1. By Country
9.5.2. By Services
9.5.3. By End user
10. Europe Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.2. Market Size (US$ Mn) and Forecast By Country
10.2.1. Germany
10.2.2. France
10.2.3. U.K.
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Market Size (US$ Mn) and Forecast By Services
10.3.1. Regulatory Writing and Publishing
10.3.2. Regulatory Submissions
10.3.3. Clinical Trial Applications and Product Registrations
10.3.4. Regulatory Consulting and Legal Representation
10.3.5. Other Regulatory Affairs
10.4. Market Size (US$ Mn) and Forecast By End user
10.4.1. Mid-Size Pharmaceutical Companies
10.4.2. Large Pharmaceutical Companies
10.4.3. Biotechnology Companies
10.4.4. Medical Devices Companies
10.4.5. Food & Beverage Companies
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Services
10.5.3. By End user
11. Asia Pacific Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.2. Market Size (US$ Mn) and Forecast By Country
11.2.1. China
11.2.2. India
11.2.3. Japan
11.2.4. ASEAN
11.2.5. Australia & New Zealand
11.2.6. Rest of Asia Pacific
11.3. Market Size (US$ Mn) and Forecast By Services
11.3.1. Regulatory Writing and Publishing
11.3.2. Regulatory Submissions
11.3.3. Clinical Trial Applications and Product Registrations
11.3.4. Regulatory Consulting and Legal Representation
11.3.5. Other Regulatory Affairs
11.4. Market Size (US$ Mn) and Forecast By End user
11.4.1. Mid-Size Pharmaceutical Companies
11.4.2. Large Pharmaceutical Companies
11.4.3. Biotechnology Companies
11.4.4. Medical Devices Companies
11.4.5. Food & Beverage Companies
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Services
11.5.3. By End user
12. Middle East & Africa (MEA) Healthcare Regulatory Affairs Outsourcing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.2. Market Size (US$ Mn) and Forecast By Country
12.2.1. GCC Countries
12.2.2. South Africa
12.2.3. Rest of MEA
12.3. Market Size (US$ Mn) and Forecast By Services
12.3.1. Regulatory Writing and Publishing
12.3.2. Regulatory Submissions
12.3.3. Clinical Trial Applications and Product Registrations
12.3.4. Regulatory Consulting and Legal Representation
12.3.5. Other Regulatory Affairs
12.4. Market Size (US$ Mn) and Forecast By End user
12.4.1. Mid-Size Pharmaceutical Companies
12.4.2. Large Pharmaceutical Companies
12.4.3. Biotechnology Companies
12.4.4. Medical Devices Companies
12.4.5. Food & Beverage Companies
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Services
12.5.3. By End user
13. Competitive Landscape (Revenue, Product Offerings, Highlights)
13.1. PAREXEL International Corporation
13.2. Quintiles IMS Holdings Inc.
13.3. Clinilabs, Inc.
13.4. Accell Clinical Research, LLC.
13.5. Freyr Solutions
13.6. The Weinberg Group Inc.
13.7. Covance, Inc., (LabCorp)
13.8. Pharmaceutical Product Development LLC
13.9. ICON plc
13.10 Sciformix Corporation
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by Services, 2022–2028
Table 02: Global Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by End User, 2022–2028
Table 03: Global Regulatory Affairs Outsourcing Market Size (US$ Mn) Forecast, by Region, 2022–2028
Table 04: North America Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by Country, 2022–2028
Table 05: North America Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by Services, 2022–2028
Table 06: North America Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by End User, 2022–2028
Table 07: Latin America Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by Country, 2022–2028
Table 08: Latin America Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by Services, 2022–2028
Table 09: Latin America Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by End User, 2022–2028
Table 10: Europe Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by Country, 2022–2028
Table 11: Europe Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by Services, 2022–2028
Table 12: Europe Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by End User, 2022–2028
Table 13: Asia Pacific Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by Country, 2022–2028
Table 14: Asia Pacific Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by Services, 2022–2028
Table 15: Asia Pacific Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by End User, 2022–2028
Table 16: MEA Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by Country, 2022–2028
Table 17: MEA Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by Services, 2022–2028
Table 18: MEA Regulatory Affairs Outsourcing Market Size (US$ Mn) and Forecast, by End User, 2022–2028
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Regulatory Affairs Outsourcing Market Size (US$ Mn) Forecast and Y-o-Y Growth Rate (%), 2022–2028
Figure 02: Global Regulatory Affairs Outsourcing Market Absolute $ Opportunity, 2021–2028
Figure 03: Market Attractiveness Analysis, By Region
Figure 04: Global Regulatory Affairs Outsourcing Market BPS Analysis, by Services, 2022 & 2028
Figure 05: Global Regulatory Affairs Outsourcing Y-o-Y Growth Rate (%), By Services, 2021–2028
Figure 06: Global Regulatory Writing and Publishing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2022–2028
Figure 07: Global Regulatory Submissions Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2022–2028
Figure 08: Global Clinical Trial Applications and Product Registrations Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2022–2028
Figure 09: Global Regulatory Consulting and Legal Representation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2022–2028
Figure 10: Global Other Regulatory Affairs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2022–2028
Figure 11: Global Regulatory Affairs Outsourcing Market Attractiveness Analysis by Services, 2012-2021
Figure 12: Global Regulatory Affairs Outsourcing Market BPS Analysis, By End User , 2022 & 2028
Figure 13: Global Regulatory Affairs Outsourcing Y-o-Y Growth Rate (%), By End User, 2021–2028
Figure 14: Global Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Mid-Size Pharmaceutical Companies
Figure 15: Global Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Large Pharmaceutical Companies 2022–2028
Figure 16: Global Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Biotechnology Companies, 2022–2028
Figure 17: Global Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Medical Devices Manufacturer, 2022–2028
Figure 18: Global Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Food & Beverage Companies, 2022–2028
Figure 19: Global Regulatory Affairs Outsourcing Market Attractiveness Analysis by End User, 2012-2021
Figure 20: Global Regulatory Affairs Outsourcing Market BPS Analysis, by Region , 2022 & 2028
Figure 21: Global Regulatory Affairs Outsourcing Y-o-Y Growth Rate (%), by Region, 2021–2028
Figure 22: North America Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 23: Latin America Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 24: Europe Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 25: Asia-Pacific Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 26: Middle East & Africa Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 27: Global Regulatory Affairs Outsourcing Market Attractiveness Analysis by Region, 2012-2021
Figure 28: North America Regulatory Affairs Outsourcing Market BPS Analysis, by Country, 2022 & 2028
Figure 29: North America Regulatory Affairs Outsourcing Y-o-Y Growth Rate (%), by Country, 2021–2028
Figure 30: U.S. Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 31: Canada Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 33: North America Regulatory Affairs Outsourcing Market Analysis by Services, 2012-2021
Figure 32: North America Regulatory Affairs Outsourcing Market Analysis by Country, 2012-2021
Figure 34: North America Regulatory Affairs Outsourcing Market Analysis by End User, 2012-2021
Figure 35: Latin America Regulatory Affairs Outsourcing Market BPS Analysis, by Country, 2022 & 2028
Figure 36: Latin America Regulatory Affairs Outsourcing Y-o-Y Growth Rate (%), by Country, 2021–2028
Figure 37: Brazil Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 38: Mexico Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 39: Rest of Latin America Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 41: Latin America Regulatory Affairs Outsourcing Market Analysis by Services, 2012-2021
Figure 40: Latin America Regulatory Affairs Outsourcing Market Analysis by Country, 2012-2021
Figure 42: Latin America Regulatory Affairs Outsourcing Market Analysis by End User, 2012-2021
Figure 43: Europe Regulatory Affairs Outsourcing Market BPS Analysis, by Country, 2022 & 2028
Figure 44: Europe Regulatory Affairs Outsourcing Y-o-Y Growth Rate (%), by Country, 2021–2028
Figure 45: UK Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 46: France Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 47: Germany Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 48: Italy Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 49: Spain Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 50: Rest of Europe Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 52: Europe Regulatory Affairs Outsourcing Market Analysis by Services, 2012-2021
Figure 51: Europe Regulatory Affairs Outsourcing Market Analysis by Country, 2012-2021
Figure 53: Europe Regulatory Affairs Outsourcing Market Analysis by End User, 2012-2021
Figure 54: Asia Pacific Regulatory Affairs Outsourcing Market BPS Analysis, by Country, 2022 & 2028
Figure 55: Asia Pacific Regulatory Affairs Outsourcing Y-o-Y Growth Rate (%), by Country, 2021–2028
Figure 56: China Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 57: India Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 58: Japan Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 59: ASEAN Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 60: Australia & New Zealand Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 61: Rest of APAC Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 63: Asia Pacific Regulatory Affairs Outsourcing Market Analysis by Services, 2012-2021
Figure 62: Asia Pacific Regulatory Affairs Outsourcing Market Analysis by Country, 2012-2021
Figure 64: Asia Pacific Regulatory Affairs Outsourcing Market Analysis by End User, 2012-2021
Figure 65: MEA Regulatory Affairs Outsourcing Market BPS Analysis, by Country, 2022 & 2028
Figure 66: MEA Regulatory Affairs Outsourcing Y-o-Y Growth Rate (%), by Country, 2021–2028
Figure 67: GCC Countries Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 68: South Africa Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 69: Rest of MEA Regulatory Affairs Outsourcing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2028
Figure 71: MEA Regulatory Affairs Outsourcing Market Analysis by Services, 2012-2021
Figure 70: MEA Regulatory Affairs Outsourcing Market Analysis by Country, 2012-2021
Figure 72: MEA Regulatory Affairs Outsourcing Market Analysis by End User, 2012-2021
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
